Drug
acalabrutinib
Marketed as CALQUENCE.
Generic name
acalabrutinib
Brand names
CALQUENCE
First FDA approval
2017-10-31
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA216387 | CALQUENCE | 2022-08-03 | ASTRAZENECA |
| NDA210259 | CALQUENCE | 2017-10-31 | ASTRAZENECA |
Manufacturers
ASTRAZENECA
Frequently asked questions
When was acalabrutinib FDA approved?
Earliest FDA approval on record: 2017-10-31.
What brand names are sold as acalabrutinib?
CALQUENCE.
Sources
Appeal a acalabrutinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com